The World Well being Group’s approval for the indigenous COVID-19 vaccine Covaxin, developed by the Hyderabad-based Bharat Biotech, is more likely to come this month, official sources mentioned Monday.
The WHO has thus far accredited Covid vaccines developed by Pfizer-BioNTech, US pharma majors Johnson & Johnson, Moderna, China’s Sinopharm and Oxford-AstraZeneca for emergency use.
Covaxin is without doubt one of the six vaccines which have acquired emergency use authorisation from India’s drug regulator and is getting used within the nationwide inoculation programme, together with Covishield and Sputnik V.
“The WHO approval for Covaxin is probably going this month,” an official supply mentioned.
The Centre had instructed Rajya Sabha in July that each one paperwork required for the WHO’s Emergency Use Itemizing (EUL) have been submitted by Bharat Biotech as of July 9, and the worldwide well being physique had commenced the assessment course of.